GeneDx Holdings Corp’s recent filing unveils that its 10% Owner OPKO HEALTH, INC. acquired Company’s shares for reported $0.55 million on Sep 17 ’24. In the deal valued at $40.88 per share,13,404 shares were bought.
Then, Stueland Katherine sold 10,501 shares, generating $394,733 in total proceeds. Upon selling the shares at $37.59, the Chief Executive Officer now owns 103,706 shares.
Before that, Feeley Kevin sold 2,635 shares. GeneDx Holdings Corp shares valued at $99,050 were divested by the CHIEF FINANCIAL OFFICER at a price of $37.59 per share. As a result of the transaction, Feeley Kevin now holds 44,472 shares, worth roughly $2.49 million.
Wells Fargo initiated its GeneDx Holdings Corp [WGS] rating to an Equal weight in a research note published on August 28, 2024; the price target was $34. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating.
Price Performance Review of WGS
On Monday, GeneDx Holdings Corp [NASDAQ:WGS] saw its stock fall -4.69% to $56.06. Over the last five days, the stock has lost -3.66%. GeneDx Holdings Corp shares have risen nearly 1938.55% since the year began. Nevertheless, the stocks have risen 1793.92% over the past one year. While a 52-week high of $61.96 was reached on 10/17/24, a 52-week low of $1.16 was recorded on 01/02/24. SMA at 50 days reached $43.75, while 200 days put it at $24.00.
Levels Of Support And Resistance For WGS Stock
The 24-hour chart illustrates a support level at 54.40, which if violated will result in even more drops to 52.74. On the upside, there is a resistance level at 59.19. A further resistance level may holdings at 62.32. The Relative Strength Index (RSI) on the 14-day chart is 58.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 54.03%. Stochastics %K at 65.05% indicates the stock is a holding.
How much short interest is there in GeneDx Holdings Corp?
A steep rise in short interest was recorded in GeneDx Holdings Corp stocks on 2024-10-15, growing by 0.19 million shares to a total of 2.4 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 2.22 million shares. There was a rise of 7.8%, which implies that there is a positive sentiment for the stock.
